User:Mr. Ibrahem/Sparsentan

Sparsentan, sold under the brand name Filspari, is a medication used to treat primary immunoglobulin A nephropathy. Specifically it is used to reduce protein in the urine. As of 2023, it is unclear if it affects long term kidney function. It is taken by mouth.

Common side effects include low blood pressure, swelling of the legs, high potassium, and low red blood cells. Severe side effects may include liver problems. Use in pregnancy may harm the baby. It is an endothelin and angiotensin II receptor blocker.

Sparsentan was approved for medical use in the United States in 2023. It is estimated to cost about 170,000 USD per year in the United States as of 2023.